Cumberland Pharmaceuticals (CPIX) Finished Goods (2011 - 2012)
Cumberland Pharmaceuticals (CPIX) reported Finished Goods of $4.9 million for Q4 2012, down 1.85% on a YoY basis from $5.0 million in Q1 2012, and down 1.85% sequentially from $5.0 million in Q4 2011.
Cumberland Pharmaceuticals (CPIX) Finished Goods (2011 - 2012) Analysis & Trends
Cumberland Pharmaceuticals (CPIX) has 2 years of Finished Goods data on file, last reported at $4.9 million in Q4 2012.
- For the quarter ending Q4 2012, Finished Goods fell 1.85% year-over-year to $4.9 million; the trailing twelve-month figure through Dec 2012 stood at $4.9 million (down 1.85% YoY), and the FY2012 full-year result was $4.9 million, down 1.85% from the prior year.
- Finished Goods declined to $4.9 million in Q4 2012, from $5.0 million in the prior quarter.
- In the past five years, Finished Goods ranged from a high of $5.0 million in Q4 2011 to a low of $4.9 million in Q4 2012.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Cumberland Pharmaceuticals | 104.57 Mn | 93.23 Mn | 7.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2012 | 4.91 Mn |
| Dec 31, 2011 | 5.00 Mn |